Pro- and anti-inflammatory factors cooperate to control hyaluronan synthesis in lung fibroblasts

American Journal of Respiratory Cell and Molecular Biology

Volumn 31, Issue 1, 2004, Pages 92-99

  Wilkinson, Thomas S ^b   Potter Perigo, Susan ^b   Tsoi, Christina ^b   Altman, Leonard C ^b   Wight, Thomas N ^a  

^a HOPE HEART INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CYTOKINE; FLUTICASONE PROPIONATE; GLUCOSAMINE; HYALURONAN SYNTHASE 2; HYALURONIC ACID; INTERLEUKIN 1BETA; ISOENZYME; MESSENGER RNA; SALMETEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG POTENTIATION; EXTRACELLULAR MATRIX; GENE INDUCTION; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL; LUNG FIBROBLAST; MOLECULAR WEIGHT; NUCLEOTIDE SEQUENCE; PNEUMONIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNTHESIS; TH1 CELL; TH2 CELL; TIME SERIES ANALYSIS;

ALBUTEROL; ANDROSTADIENES; ANTI-INFLAMMATORY AGENTS; ASTHMA; BRONCHI; CELLS, CULTURED; CYTOKINES; DRUG INTERACTIONS; FIBROBLASTS; GLUCOSAMINE; GLUCURONOSYLTRANSFERASE; HUMANS; HYALURONIC ACID; INFLAMMATION MEDIATORS; INTERLEUKIN-1; LUNG; PNEUMONIA; RNA, MESSENGER; TH1 CELLS; TH2 CELLS; TRANSFERASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 3042838546     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2003-0380OC     Document Type: Article

References (53)

1. Elias, J. A., Z. Zhu, G. Chupp, and R. J. Homer. 1999. Airway remodeling in asthma. J. Clin. Invest. 104:1001-1006.
2. Beasley, R., C. Page, and L. Lichtenstein. 2002. Airway remodelling in asthma. Clin. Exp. Allergy Rev. 2:109-116.
3. Fahy, J. V., D. B. Corry, and H. A. Boushey. 2000. Airway inflammation and remodeling in asthma. Curr. Opin. Pulm. Med. 6:15-20.
4. Jeffery, P. K. 2001. Remodeling in asthma and chronic obstructive lung disease. Am. J. Respir. Crit. Care Med. 164:S28-S38.
5. Umetsu, D. T., J. J. McIntire, O. Akbari, C. Macaubas, and R. H. DeKruyff. 2002. Asthma: an epidemic of dysregulated immunity. Nat. Immunol 3:715-720.
6. Beckett, P. A., and P. H. Howarth. 2003. Pharmacotherapy and airway remodelling in asthma? Thorax 58:163-174.
7. Matz, J., A. Emmett, K. Rickard, and C. Kalberg. 2001. Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: an analysis of asthma exacerbations. J. Allergy Clin. Immunol. 107:783-789.
8. Kavuru, M., J. Melamed, G. Gross, C. Laforce, K. House, B. Prillaman, L. Baitinger, A. Woodring, and T. Shah. 2000. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial. J. Allergy Clin. Immunol. 105:1108-1116.
9. Kirby, S., C. Falcoz, M. J. Daniel, S. Milleri, L. Squassante, L. Ziviani, and G. P. Ventresca. 2001. Salmeterol and fluticasone propionate given as a combination. Lack of systemic pharmacodynamic and pharmacokinetic interactions. Eur. J. Clin. Pharmacol. 56:781-791.
10. Godfrey, R. W., S. Lorimer, S. Majumdar, E. Adelroth, P. W. Johnston, A. V. Rogers, S. A. Johansson, and P. K. Jeffery. 1995. Airway and lung elastic fiber is not reduced in asthma nor in asthmatics following corticosteroid treatment. Eur. Respir. J. 8:922-927.
11. Itano, N., T. Sawai, M. Yoshida, P. Lenas, Y. Yamada, M. Imagawa, T. Shinomura, M. Hamaguchi, Y. Yoshida, Y. Ohnuki, S. Miyauchi, A. P. Spicer, J. A. McDonald, and K. Kimata. 1999. Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J. Biol. Chem. 274: 25085-25092.
12. Recklies, A. D., C. White, L. Melching, and P. J. Roughley. 2001. Differential regulation and expression of hyaluronan synthases in human articular chondrocytes, synovial cells and osteosarcoma cells. Biochem. J. 354:17-24.
13. Jacobson, A., J. Brinck, M. J. Briskin, A. P. Spicer, and P. Heldin. 2000. Expression of human hyaluronan synthases in response to external stimuli. Biochem. J. 348:29-35.
14. Forteza, R., T. Lieb, T. Aoki, R. C. Savani, G. E. Conner, and M. Salathe. 2001. Hyaluronan serves a novel role in airway mucosal host defense. FASEB J. 15:2179-2186.
15. Bray, B. A. 2001. The role of hyaluronan in the pulmonary alveolus. J. Theor. Biol. 210:121-130.
16. Bray, B. A., P. M. Sampson, M. Osman, A. Giandomenico, and G. M. Turino. 1991. Early changes in lung tissue hyaluronan (hyaluronic acid) and hyaluronidase in bleomycin-induced alveolitis in hamsters. Am. Rev. Respir. Dis. 143:284-288.
17. Savani, R. C., G. Hou, P. Liu, C. Wang, E. Simons, P. C. Grimm, R. Stern, A. H. Greenberg, H. M. DeLisser, and N. Khalil. 2000. A role for hyaluronan in macrophage accumulation and collagen deposition after bleomycin-induced lung injury. Am. J. Respir. Cell Mol. Biol. 23:475-484.
18. Teder, P., O. Nettelbladt, and P. Heldin. 1995. Characterization of the mechanism involved in bleomycin-induced increased hyaluronan production in rat lung. Am. J. Respir. Cell Mol. Biol. 12:181-189.
19. Teder, P., R. W. Vandivier, D. Jiang, J. Liang, L. Cohn, E. Pure, P. M. Henson, and P. W. Noble. 2002. Resolution of lung inflammation by CD44. Science 296:155-158.
20. Sahu, S., and W. S. Lynn. 1978. Hyaluronic acid in the pulmonary secretions of patients with asthma. Biochem. J. 173:565-568.
21. McKee, C. M., M. B. Penno, M. Cowman, M. D. Burdick, R. M. Strieter, C. Bao, and P. W. Noble. 1996. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J. Clin. Invest. 98:2403-2413.
22. Horton, M. R., M. D. Burdick, R. M. Strieter, C. Bao, and P. W. Noble. 1998. Regulation of hyaluronan-induced chemokine gene expression by IL-10 and IFN-gamma in mouse macrophages. J. Immunol. 160:3023-3030.
23. Horton, M. R., M. A. Olman, and P. W. Noble. 1999. Hyaluronan fragments induce plasminogen activator inhibitor-1 and inhibit urokinase activity in mouse alveolar macrophages: a potential mechanism for impaired fibrinolytic activity in acute lung injury. Chest 116:175.
24. Horton, M. R., S. Shapiro, C. Bao, C. J. Lowenstein, and P. W. Noble. 1999. Induction and regulation of macrophage metalloelastase by hyaluronan fragments in mouse macrophages. J. Immunol. 162:4171-4176.
25. Tonnel, A. B., P. Gosset, and I. Tillie-Lefalond. 2001. Characteristics of the Inflammatory response in bronchial lavage fluids from patients with status asthmaticus. Int. Arch. Allergy Immunol. 124:267-271.
26. Bodey, K. J., A. E. Semper, A. E. Redington, J. Madden, L. M. Teran, S. T. Holgate, and A. J. Frew. 1999. Cytokine profiles of BAL T cells and T-cell clones obtained from human asthmatic airways after local allergen challenge. Allergy 54:1083-1093.
27. Walker, C., E. Bode, L. Boer, T. T. Hansel, K. Blaser, and J. C. Virchow, Jr. 1992. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am. Rev. Respir. Dis. 146:109-115.
28. Tufvesson, E., and G. Westergren-Thorsson. 2000. Alteration of proteoglycan synthesis in human lung fibroblasts induced by interleukin-1beta and tumor necrosis factor-alpha. J. Cell. Biochem. 77:298-309.
29. Hoshino, Y., T. Mio, S. Nagai, I. Ito, M. Shigematsu, and T. Izumi. 2001. Fibrogenic and inflammatory cytokines modulate mRNA expressions of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-3 in type II pneumocytes. Respiration (Herrlisheim) 68:509-516.
30. Hozumi, A., Y. Nishimura, T. Nishiuma, Y. Kotani, and M. Yokoyama. 2001. Induction of MMP-9 in normal human bronchial epithelial cells by TNF-alpha via NF-kappa B-mediated pathway. Am. J. Physiol. Lung Cell. Mol. Physiol. 281:L1444-L1452.
31. Elias, J. A., B. Freundlich, S. Adams, and J. Rosenbloom. 1990. Regulation of human lung fibroblast collagen production by recombinant interleukin-1, tumor necrosis factor, and interferon-gamma. Ann. N. Y. Acad. Sci. 580:233-244.
32. Rishikof, D. C., D. A. Ricupero, P. P. Kuang, H. Liu, and R. H. Goldstein. 2002. Interleukin-4 regulates connective tissue growth factor expression in human lung fibroblasts. J. Cell. Biochem. 85:496-504.
33. Hashimoto, S., Y. Gon, I. Takeshita, S. Maruoka, and T. Horie. 2001. IL-4 and IL-13 induce myofibroblastic phenotype of human lung fibroblasts through c-Jun NH2-terminal kinase-dependent pathway. J. Allergy Clin. Immunol. 107:1001-1008.
34. Lipscombe, R. J., A. M. Nakhoul, C. J. Sanderson, and D. R. Coombe. 1998. Interleukin-5 binds to heparin/heparan sulfate. A model for an interaction with extracellular matrix. J. Leukoc. Biol. 63:342-350.
35. Green, S. J., G. Tarone, and C. B. Underhill. 1988. Distribution of hyaluronate and hyaluronate receptors in the adult lung. J. Cell Sci. 89:145-156.
36. Raghu, G., Y. Y. Chen, V. Rusch, and P. S. Rabinovitch. 1988. Differential proliferation of fibroblasts cultured from normal and fibrotic human lungs. Am. Rev. Respir. Dis. 138:703-708.
37. Underhill, C. B., H. A. Nguyen, M. Shizari, and M. Culty. 1993. CD44 positive macrophages take up hyaluronan during lung development. Dev. Biol. 155: 324-336.
38. West, D. C., A. Sattar, and S. Kumar. 1985. A simplified in situ solubilization procedure for the determination of DNA and cell number in tissue cultured mammalian cells. Anal. Biochem. 147:289-295.
39. Chomczynski, P. 1993. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 15:532-4. 536-7.
40. Sampson, P. M., C. L. Rochester, B. Freundlich, and J. A. Elias. 1992. Cytokine regulation of human lung fibroblast hyaluronan (hyaluronic acid) production. Evidence for cytokine-regulated hyaluronan (hyaluronic acid) degradation and human lung fibroblast-derived hyaluronidase. J. Clin. Invest 90:1492-1503.
41. Monslow, J., J. D. Williams, N. Norton, C. A. Guy, I. K. Price, S. L. Coleman, N. M. Williams, P. R. Buckland, A. P. Spicer, N. Topley, M. Davies, and T. Bowen. 2003. The human hyaluronan synthase genes: genomic structures, proximal promoters and polymorphic microsatellite markers. Int. J. Biochem. Cell Biol. 35:1272-1283.
42. Ohkawa, T., N. Ueki, T. Taguchi, Y. Shindo, M. Adachi, Y. Amuro, T. Hada, and K. Higashino. 1999. Stimulation of hyaluronan synthesis by tumor necrosis factor-alpha is mediated by the p50/p65 NF-kappa B complex in MRC-5 myofibroblasts. Biochim. Biophys. Acta 1448:416-424.
43. Zhu, Z., B. Ma, T. Zheng, R. J. Homer, C. G. Lee, I. F. Charo, P. Noble, and J. A. Elias. 2002. IL-13-induced chemokine responses in the lung: role of CCR2 in the pathogenesis of IL-13-induced inflammation and remodeling. J. Immunol. 168:2953-2962.
44. Leonard, W. J., and J. J. O'Shea. 1998. Jaks and stats: biological implications. Annu. Rev. Immunol. 16:293-322.
45. Wight, T. N., M. G. Kinsella, and E. E. Qwarnstrom. 1992. The role of proteoglycans in cell adhesion, migration and proliferation. Curr. Opin. Cell Biol. 4:793-801.
46. de La Motte, C. A., V. C. Hascall, A. Calabro, B. Yen-Lieberman, and S. A. Strong. 1999. Mononuclear leukocytes preferentially bind via CD44 to hyaluronan on human intestinal mucosal smooth muscle cells after virus infection or treatment with poly(I.C). J. Biol. Chem. 274:30747-30755.
47. de la Motte, C., V. Hascall, J. Drazba, and S. Strong. 2002. Poly I:C induces mononuclear leukocyte-adhesive hyaluronan structure on colon smooth muscle cells:IαI and versican facilitate adhesion. In Hyaluronan, First Edition. J. Kennedy, G. Phillips, P. Williams and V. Hascall, editors. Woodhead Publishing Ltd, Cambridge. 381-388.
48. Li, Y., M. Rahmanian, C. Widstrom, G. Lepperdinger, G. I. Frost, and P. Heldin. 2000. Irradiation-induced expression of hyaluronan (HA) synthase 2 and hyaluronidase 2 genes in rat lung tissue accompanies active turnover of HA and induction of types I and III collagen gene expression. Am. J. Respir. Cell Mol. Biol 23:411-418.
49. Ghatak, S., S. Misra, and B. P. Toole. 2002. Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway. J. Biol. Chem. 277: 38013-38020.
50. Zhang, W., C. E. Watson, C. Liu, K. J. Williams, and V. P. Werth. 2000. Glucocorticoids induce a near-total suppression of hyaluronan synthase mRNA in dermal fibroblasts and in osteoblasts: a molecular mechanism contributing to organ atrophy. Biochem. J. 349:91-97.
51. Silvestri, M., L. Fregonese, F. Sabatini, G. Dasic, and G. A. Rossi. 2001. Fluticasone and salmeterol downregulate in vitro, fibroblast proliferation and ICAM-1 or H-CAM expression. Eur. Respir. J. 18:139-145.
52. Auphan, N., J. A. Didonato, C. Rosette, A. Helmberg, and M. Karin. 1995. Immunosuppression by glucocorticoids:inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270:286-290.
53. Farmer, P., and J. Pugin. 2000. β-Adrenergic agonists exert their anti-inflammatory effects in monocytic cells through the IκB/NF-κB pathway. Am. J. Physiol. Lung Cell. Mol. Physiol. 279:L675-L682.